Immunic
IMUX
55 hedge funds and large institutions have $37.5M invested in Immunic in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
119% more call options, than puts
Call options by funds: $219K | Put options by funds: $100K
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
8% more funds holding
Funds holding: 51 → 55 (+4)
0.07% more ownership
Funds ownership: 0% → 0.07% (+0.07%)
28% less capital invested
Capital invested by funds: $52.1M → $37.5M (-$14.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.04M |
| 2 |
Morgan Stanley
New York
|
+$348K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$339K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$274K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$263K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.79M |
| 2 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
-$184K |
| 3 |
ProShare Advisors
Bethesda,
Maryland
|
-$136K |
| 4 |
Goldman Sachs
New York
|
-$94.2K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$81K |
IMUX Hedge Fund Activity: Q4 2016 in Review
55 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q4 2016, worth a combined $37.5M — down 28% from $52.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IMUX positions and 4 closed out — a net gain of 5 holders — while 17 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.04M. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.79M.
- 55 institutional investors held Immunic (IMUX) as of Q4 2016, up from 51 in Q3 2016.
- Funds reported $37.5M of Immunic stock for Q4 2016, down 28% quarter-over-quarter.
- 9 funds opened new Immunic positions in Q4 2016 and 4 closed out, a net change of +5 holders.
- The largest Immunic buyer in Q4 2016 was Millennium Management, an estimated $1.04M added.
- The largest Immunic seller in Q4 2016 was BlackRock Fund Advisors, an estimated $1.79M sold.
Based on aggregated 13F filings for Q4 2016.